Andreas Busch

Insider Reports History

Location
C/O Cyclerion Therapeutics, Inc., 301 Binney Street, Cambridge, MA
Signature
/s/ Shelby Walker, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andreas Busch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Absci Corp Chief Innovation Officer Common Stock 324K $1.19M $3.68 Oct 14, 2025 Direct
Cyclerion Therapeutics, Inc. Chief Scientific Officer Employee Stock Option (Right to Buy) 135K Jan 20, 2022 Direct
Absci Corp Chief Innovation Officer Stock Option (right to buy) 93.7K Mar 3, 2025 Direct

Insider Reports Filed by Andreas Busch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABSI Absci Corp Oct 14, 2025 1 -$11.4K 4 Oct 14, 2025 Chief Innovation Officer
ABSI Absci Corp Jul 28, 2025 1 $152K 4 Jul 29, 2025 Chief Innovation Officer
ABSI Absci Corp Mar 3, 2025 2 $0 4 Mar 4, 2025 Chief Innovation Officer
ABSI Absci Corp Feb 1, 2025 1 -$5.45K 4 Feb 4, 2025 Chief Innovation Officer
ABSI Absci Corp Oct 12, 2024 1 -$12.6K 4 Oct 16, 2024 Chief Innovation Officer
ABSI Absci Corp Feb 1, 2024 2 $0 4 Feb 5, 2024 Chief Innovation Officer
ABSI Absci Corp Oct 12, 2023 1 $0 4 Oct 16, 2023 Chief Innovation Officer
ABSI Absci Corp Mar 1, 2023 1 $0 4 Mar 3, 2023 Chief Innovation Officer
ABSI Absci Corp Oct 3, 2022 1 $0 4 Oct 5, 2022 Chief Innovation Officer
ABSI Absci Corp Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
ABSI Absci Corp Mar 17, 2022 1 $0 4 Mar 21, 2022 Director
ABSI Absci Corp Mar 17, 2022 0 $0 3 Mar 21, 2022 Director
CYCN Cyclerion Therapeutics, Inc. Jan 20, 2022 1 $0 4 Jan 24, 2022 Chief Scientific Officer
CYCN Cyclerion Therapeutics, Inc. Dec 9, 2021 1 $0 4 Dec 10, 2021 Chief Scientific Officer